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Enhancing Success of Medicare’s Shared
Decision Making Mandates Using
Implementation Science: Examples Applying
the Pragmatic Robust Implementation and
Sustainability Model (PRISM)
Daniel D. Matlock , Mayuko Ito Fukunaga , Andy Tan , Chris Knoepke ,
Demetria M. McNeal, Kathleen M. Mazor, and Russell E. Glasgow
The Centers for Medicare and Medicaid Services (CMS) has mandated shared decision making (SDM) using patient
decision aids for three conditions (lung cancer screening, atrial fibrillation, and implantable defibrillators). These
forward-thinking approaches are in response to a wealth of efficacy data demonstrating that decision aids can
improve patient decision making. However, there has been little focus on how to implement these approaches in real-
world practice. This article demonstrates how using an implementation science framework may help programs under-
stand multilevel challenges and opportunities to improve adherence to the CMS mandates. Using the PRISM
(Pragmatic Robust Implementation and Sustainability Model) framework, we discuss general challenges to imple-
mentation of SDM, issues specific to each mandate, and how to plan for, enhance, and assess SDM implementation
outcomes. Notably, a theme of this discussion is that successful implementation is context-specific and to truly have
successful and sustainable changes in practice, context variability, and adaptation to context must be considered and
addressed.
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Evidence-Based Patient Decision Aids (DAs) Are
Mandated but Not Widely Adopted
Patient-centered care is increasingly recognized as impor-
tant for both practical and political reasons. As a pri-
mary process of involving patients directly in their care,
shared decision making (SDM) is explicitly supported by
the Institutes of Medicine1 and the Affordable Care Act.2
The Food and Drug Administration has recently begun
the Patient Preference Initiative, which incorporates the
patient perspective into regulatory decision making,3 and
SDM is considered part of the approval process for new
drugs and devices. Recently, the Centers for Medicare
and Medicaid services (CMS) has instituted requirements
for SDM with the use of DAs as a condition of reimbur-
sement for lung cancer screening, left atrial appendage
closure (LAAC) device placement, and implantable car-
dioverter defibrillators (ICD; Table 1).4–6
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DAs are evidence-based tools to potentially improve
quality of patient-centered care and communication. A
Cochrane review of 105 randomized trials concluded that
DAs can improve patients’ knowledge, satisfaction,
patient/clinician communication, increase patient invol-
vement in decision making, and reduce patient decisional
conflict and regret.7 DAs are available in many forms
including paper, video,8 interactive web sites,9 and even
telenovelas.10 However, despite their efficacy in con-
trolled trials, DAs have seldom been adopted into real-
world clinical practice. A recent systematic review of DA
implementation identified a host of logistical barriers,
including clinicians’ perception of time necessary to use
DAs, lack of reimbursement, and perceived bias inherent
in the DAs themselves.11 Indeed, the lack of understand-
ing of how to implement DAs in clinical practice has led
some to call the CMS mandates premature.12
SDM is a process in which patients and physicians
collaborate to make decisions based on the best available
evidence of the likelihood of risks and benefits, taking
into account patient preferences. While DAs can support
SDM especially in information exchange (or delivery),
the use of a DA alone does not ensure that quality SDM
will occur. Many DAs are publicly available, meaning
that patients can review the DA independently of an
encounter with a physician. Patients who review a DA
may choose to decline a screening or intervention with-
out talking to their clinicians. If a DA is used simply to
fill a ‘‘checkbox’’ to meet the CMS mandate, and the
clinician reverts to less patient-centered styles of commu-
nication without discussing patients’ preference and
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Table 1 Recent Policy Decisions Mandating Shared Decision Making
Lung cancer
screening4
‘‘. . . a beneficiary must receive a written order for LDCT lung cancer screening during a lung cancer
screening counseling and shared decision making visit, furnished by a physician . . . or qualified non-
physician practitioner. . . . A lung cancer screening counseling and shared decision making visit
includes the following elements:
 Determination of beneficiary eligibility including age, absence of signs or symptoms of lung
cancer, a specific calculation of cigarette smoking pack-years; and if a former smoker, the number
of years since quitting;
 Shared decision making, including the use of one or more decision aids, to include benefits and
harms of screening, follow-up diagnostic testing, overdiagnosis, false positive rate, and total
radiation exposure;
 Counseling on the importance of adherence to annual lung cancer LDCT screening, impact of
comorbidities and ability or willingness to undergo diagnosis and treatment; and
 Counseling on the importance of maintaining cigarette smoking abstinence if former smoker; or




‘‘A formal shared decision making interaction with an independent non-interventional physician using
an evidence-based decision tool on oral anticoagulation in patients with NVAF prior to LAAC.




‘‘For these patients . . . a formal shared decision making encounter must occur between the patient
and a physician . . . or qualified non-physician practitioner (meaning a physician assistant, nurse
practitioner, or clinical nurse specialist) . . . using an evidence-based decision tool on ICDs prior to
initial ICD implantation. The shared decision making encounter may occur at a separate visit.’’
ICD, implantable cardioverter defibrillator; LAAC, left atrial appendage closure; LDCT, low-dose computed tomography; NVAF, nonvalvular
atrial fibrillation.
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values, then SDM has not been achieved. Thus, a major
gap exists between these mandates for DAs and real-
world implementation of quality SDM—and this is a
major criticism of the mandates from clinicians.12 The
goal of this article is to consider recent mandates from
the perspective of the Practical Robust Implementation
and Sustainability Model (PRISM) framework—to
explore and address issues in translating mandates for
SDM and DAs into widespread clinical practice.13
Implementation Science as a Bridge Between
Research and Practice
Implementation science can help address the gap between
research and practice.14,15 Implementation science has
multiple conceptual frameworks, strategies, and measures
that can be utilized to plan, support implementation,
enhance sustainability, and evaluate the process and out-
comes of strategies to implement SDM interventions.16
Which frameworks, implementation strategies, and
assessment procedures are used depends on the problem,
context, and especially the fit among the intervention, the
context, and the implementation strategies.17
The PRISM13,18 framework is a lens to clarify the
issues involved in planning for implementation, and to
guide efforts to evaluate SDM interventions and DAs.
PRISM is an expansion of the more widely known
Reach, Effectiveness, Adoption, Implementation and
Maintenance (RE-AIM) framework19 to evaluate con-
textual factors, process, and outcomes of efforts to trans-
late research into practice. We selected PRISM because
this framework focuses on key factors important to—
and measures of—implementation success, is intuitive,
and emphasizes the importance of attending to the fit
between the evidence-based intervention, the implemen-
tation strategy, and how they link context to outcomes.18
In brief, PRISM focuses attention on several key con-
textual factors that influence program implementation,
process, and outcomes. These factors, listed in Table 2,
include the following: 1) the intervention (implications
for both organizational and patient perspectives); 2) mul-
tilevel recipients (both organizational- and patient-level
characteristics); 3) implementation and sustainability
infrastructure; and 4) external environment (including
guidelines, policies, and reimbursement issues).
The contextual factors in PRISM are hypothesized to
determine the five RE-AIM implementation outcomes
discussed below (Table 3). Relying on a framework like
PRISM at the initiation of an implementation experience
and then using it in the planning, implementation, eva-
luation, and dissemination (if appropriate) phases can
enhance implementation success while simultaneously
advancing the science by allowing implementation strate-
gies to be linked to larger constructs.20 Local contexts
are different, change over time, and need to be addressed
with appropriate adaptations to ensure continuing fit
with context and culture.21,22 This is a key tenet of imple-
mentation science and contrasts with the usual focus on
complete fidelity to the original protocol and all compo-
nents of the evidence-based intervention. Adaptations
occur throughout the implementation process, including
during the planning, delivery, evaluation, and sustain-
ability phases23; and implementation science can help
understand, assess, and potentially guide such adapta-
tions to make them more effective.
The PRISM Lens Can Enhance Success
in Implementing SDM and DAs
This section illustrates how the domains of the PRISM
framework can be utilized to enhance the implementation
and sustainability of the recent policy mandates to utilize
DAs for facilitating SDM (Table 2 and Figure 1).
PRISM Contextual Domain: Intervention
One important underrecognized opportunity to improve
implementation is in the design of the DAs themselves
and selection of DA to meet the needs of patients, clini-
cians, and each clinical setting. While the International
Patient Decision Aid Standards Collaboration has done
excellent work advancing design features to make DAs
effective from the standpoint of patient education and
value-choice concordance, these standards have not been
translated into design features that make them feasible
and easy to use in a variety of real-world clinical settings.
Different decision contexts need different DA designs.24
It is conceivable that patients may be willing to watch a
longer video-based DA before a high-stakes procedure
like an implantable defibrillator or a LAAC device, while
they may want a much shorter, encounter-based DA to
go over with their clinicians during the visit regarding
a decision to take anticoagulation medications to pre-
vent stroke or to get a test for lung cancer screening.
Depending on patients’ characteristics, some patients
may require assistance to use a web-based DA. Different
types of clinicians providing SDM counseling to patients
during the encounter have different needs, which should
be acknowledged and built into DAs to enhance clinician
adoption. DAs must be designed with input from all
end-users and must be designed with understanding of
the context within which they will be implemented.25





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































From the organization’s perspective, it would be impor-
tant to communicate the evidence base of offering coun-
seling and SDM visits, and to engage clinicians in DA
development or selection to help increase the readiness
of clinicians to integrate counseling and SDM within
their existing clinical workflow. From the patient’s per-
spective, it would be important to ensure that the process
of counseling and SDM with the use of DA is patient
centered, address patient-level barriers, and minimize the
burden and costs, as well as incorporate more general
health communication principles such as responding to
emotions that may arise and managing uncertainty.26
Since development of DAs itself is extensive work and
involves field testing of DAs with patients and providers,
peer review by patients and experts in the field who are
not involved in development or field testing of DAs,
thinking about development of DAs from implementa-
tion point of view and adding a few more stakeholders
such as a hospital leadership or IT in this process is small
additional work that will allow DAs to be widely used in
a real world. DAs are living documents, and one way to
defray the costs is to do some of this evaluation postim-
plementation allowing the DA to be adapted over time
to meet the needs of end-users.
Another intervention and ‘‘fit’’ issue is whether ade-
quate time for SDM discussions is built into the system.
Time is one of the most frequently cited barriers to use
of SDM in order to meet these mandates.27,28 Systems
need to make time in already busy clinical schedules for
this work or they need to empower other clinical staff
such as nurses to help initiate these conversations with
patients. This may be enhanced with system-wide efforts
to increase SDM usage and ultimately leading to culture
change. How the DAs are made available is also impor-
tant. An encounter-based DA that is not easily accessible
in the clinical visit is unlikely to be adopted, implemented
consistently or sustained. Likewise, a self-administered
DA that is difficult to access will not be used by patients
prior to a visit. Limited access to DAs could be partially
solved by user-centered designed health informatic sup-
port. Finally, health care systems can further support
clinicians by investing in training on essential communi-
cation skills and provide feedback on the patient-
centeredness of their communication strategies.
PRISM Contextual Domain: Multilevel
Recipients
At the organizational level, obtaining clinical leadership
and management support, instituting systems and train-































































































































































































































































































































































































































































































































































































































































6 MDM Policy & Practice 00(0)
critical to enhancing the implementation and sustainabil-
ity of counseling and SDM in a clinical workflow. A
major barrier to implementing SDM is overcoming clini-
cians’ beliefs that they know how to do SDM and that
they are already doing it.27 One strategy that is often
used but ineffective is telling clinicians that they are
doing a poor job communicating with patients and that
they should use a DA to improve their communication.12
A better approach is acknowledging that clinicians are
striving to provide excellent care to their patients and
that communication can be difficult. This framing of
DAs as an intervention to help and that DAs are
designed support challenging discussions may be more
successful. Also, direct feedback from patients regarding
their preferred role in decision making and their current
understanding of the decision may be additional data to
help clinicians engage in SDM discussions. Furthermore,
reassuring clinicians that DAs are not meant to under-
mine their relationship or replace discussions with their
patients is also an important strategy when implementing
DAs. At the patient level, individual patients have differing
levels of health literacy, numeracy, internet access, or abil-
ity to utilize online patient education resources (including
DAs). In addition, patients may experience vision, hearing,
and cognitive issues. Therefore, the delivery of DAs and
SDM visit should address these patients’ specific needs but
tailoring DA to individual patient needs is challenging,
and is typically not done.29 Clinicians seeking to tailor
their approach to SDM for different patients have had
limited guidance. Additionally, there are usually also
larger organizational-level factors such as culture,
implementation climate,30 emphasis on profit, and vol-
ume requirements to preserve the ability to perform
certain procedures. These organizational concerns can
also be strong influencers of whether an organization
supports SDM.
PRISM Contextual Domain: Implementation
and Sustainability Infrastructure
An important and unique element of PRISM is the atten-
tion to the importance of the implementation and sus-
tainability infrastructure built into a system to increase
chances of long-term maintenance. As applied to DAs
and SDM, there are several structural considerations for
health care systems to help create a culture supportive of
SDM such as job descriptions and onboarding (for new
staff to be trained in SDM), performance assessment pro-
cedures, incorporation into workflow, ongoing audit and
feedback, and adequate financial and other resources
that influence levels of successful implementation and
long-term sustainability. Additionally, much of SDM
could be easily implemented through telehealth, which is
rapidly gaining traction as we adjust to the COVID-19
pandemic.
Figure 1 PRISM logic model of implementation of a shared decision-making program.
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PRISM Contextual Domain: External
Environment
There is an ever-increasing external pressure for the care
provided to patients to be more patient-centered.27 The
increased influence of patient experience measures and
the surge in the number of patient advocacy groups is
strong evidence of this changing expectation of health
care.31 This shift is now represented in professional soci-
ety guidelines, which increasingly call for greater inclu-
sion of SDM in patient care.32 Perhaps the strongest
external environment motivator of implementation is
linking the behavior to payment—indeed the motivation
behind this article is to discuss the implementation of
new CMS mandates, which require documentation that
SDM has occurred for reimbursement. While clinicians
reactions to these mandates has been mixed,12 the fact
that they exist has intensified the discussions about how
to make SDM occur.
Specific Issues Related to Each Individual
Mandate
The CMS mandates provided no discussion of implemen-
tation and organizational context or guidance on how
they should be implemented. Each mandate also included
unique challenges as viewed through the PRISM lens (see
Table 2).
Lung Cancer Screening
CMS has mandated that patients receive counseling and
SDM with the use of a DA prior to receiving a low-dose
computed tomography (LDCT). The SDM visit is reim-
bursed by CMS separately from LDCT for lung cancer
screening. The counseling and SDM visit should include
several elements listed in Table 1.4 From a PRISM per-
spective, this is a complicated, multimodal intervention.
The first challenge unique to lung cancer screening is in
identifying screening-eligible patients, as doing so
requires a detailed smoking history. Building a system in
a clinical workflow that accurately identifies lung cancer
screening eligible patients will offset some of the burden
from clinicians. Several lung cancer screening DAs have
been developed; several have been evaluated and most
were found to be acceptable to patients and improve
decision outcomes. Some lung cancer screening DAs
result in improved patient knowledge, and reduce deci-
sional conflict.33–35 However, most studies evaluated
DAs in a research setting outside of a real-world clinical
workflow and these DAs likely need to be adapted and
simplified for implementation in low-resource primary
care settings health systems serving diverse patient popu-
lations, or in low-resource settings such as rural clinics
or federally qualified health centers. CMS left the deci-
sion of which DA and how to use it in a clinical work-
flow to clinicians and health systems. From a recipient
perspective, as patients are either current or former smo-
kers, the counseling including tobacco cessation (or sus-
tained abstinence) and the SDM visit should be sensitive,
avoiding exacerbating smoking-related stigma and lung
cancer worry in this population. Likewise, primary care
clinicians are expected to play an important role in these
discussions and many may not be well informed of the
detailed risks and benefits of lung cancer screening.36
Finally, from an implementation and sustainability
infrastructure perspective, many primary care practices
are not prepared or structured to engage in and support
SDM about lung cancer screening with patients.37 While
much of the literature on SDM focuses on the primary
care setting,37 a number of alternative approaches have
been considered and some have been tested. The Cleve-
land Clinic tested an alternate model, where primary care
clinicians referred potentially eligible patients to a central
lung cancer screening program to conduct the counseling
and SDM visit.38 Telephone counseling for SDM may
hold promise as a way of supporting busy clinicians with-
out burdening patients with the need for an additional
visit, although CMS currently mandates that SDM occur
during an in-person visit.39,40 To improve implementation
of this mandate, clinicians need clarity about coverage of
LDCT screening, tools for patient education, and enga-
ging in SDM. Effective implementation toolkits and train-
ing for all frontline staff potentially involved would
increase the readiness for primary care clinicians to imple-
ment SDM around lung cancer screening.37 Incorporation
of SDM into office flow and staff performance expecta-
tions would enhance probability of sustainment and allow
the program to reevaluate and adopt the process when
external environmental factor changes such as COVID-19
pandemic. With COVID-19 pandemic and significant
uptake of telemedicine, CMS mandates of in-person SDM
visit needs to be revisited and telehealth SDM counseling
needs to be reimbursed to continue providing quality
SDM.
Atrial Fibrillation Stroke Reduction
With respect to stroke prevention in patients with atrial
fibrillation (AF), the external environment is quite strong
as SDM is recommended by professional guidelines,41 is
an endorsed quality measure,42 and is mandated by the
8 MDM Policy & Practice 00(0)
CMS National Coverage Determination (NCD) for
LAAC (Table 1). However, the state of SDM in AF is
poor. Significant gaps exist in patients’ knowledge about
the risks and benefits of stroke reduction options,43 and
patients often report a paternalistic decision-making pro-
cess with their clinicians.44 From an intervention perspec-
tive, there are several DAs for stroke reduction options;
however, few include the LAAC device—which is the
specific context in which the mandate exists. From a reci-
pient perspective, clinicians who perform LAAC proce-
dures have been frustrated by the mandate that the
SDM discussion must occur with a non-proceduralist
clinician.12 This also creates a challenge from the per-
spective of multilevel recipients and the implementation
and sustainability infrastructure. The NCD for LAAC
explicitly states that the SDM conversation used to meet
the mandate must be conducted by a ‘‘non-intervention-
ist physician,’’ thereby tying reimbursement for an even-
tual procedure to a conversation that occurred with a
different clinician. This creates a constellation of misa-
ligned incentives and complications, including the impli-
cation that proceduralist physicians who ultimately care
for patients are more likely to inappropriately guide
them toward having a procedure.45,46 By alienating pro-
ceduralists, who typically oversee the operations of speci-
alty electrophysiology and interventional cardiology
practices, this requirement reduces the likelihood that
the mandate would be adhered to in an earnest manner.
To improve implementation of this mandate, clinicians
need tools that support conversations for stroke reduc-
tion that are easy, tailored to local context, and feasible
to use and implement both in primary and specialty care,
and the incentive for the SDM discussion needs to be
better aligned with the clinician who is actually doing the
discussion as opposed to the ‘‘non-interventionist’’ lan-
guage discussed above.
Implantable Cardioverter Defibrillators
The current NCD addressing reimbursement for ICD
therapy for primary prevention of risk of sudden cardiac
death involves decision-specific features which influence
the design and implementation of patient decision sup-
port processes. From an intervention perspective, the
requirement includes documented use of an ‘‘evidence-
based’’ DA as part of the patient education process.
While the NCD links to one such tool as an example, the
language itself does not describe a list of approved DAs
or a process by which to assess whether other ones are
‘‘evidence based.’’ From a multilevel recipient perspective,
there is no agreement among clinicians that defibrillators
are a preference sensitive decision—believing that the
benefits in survival outweigh any harms. Consequently,
using a DA risks being a ‘‘check box’’ on the path toward
a paternalistic recommendation to perform a procedure.
Patients likewise hear words like ‘‘sudden cardiac death’’
and may resort to making decisions based on uninformed
or emotional heuristics.47 As such, implementing this
CMS mandate requires extra attention directed toward
clinicians. Considering intervention and implementation
and sustainability infrastructure perspectives, tools need
to be designed in a way that not only helps patients make
decisions but also delivered in a context so that clinicians
are willing to use them and that fits their environment,
staffing, and workflow.
Evaluation: RE-AIM Outcomes as Applied
to SDM (Table 3)
The PRISM framework was built upon the RE-AIM
framework to add the important contextual elements
described above. Table 3 presents the five core concepts
of the RE-AIM evaluation framework as applied to SDM.
The conceptualization is relatively straightforward—the
challenge lies in identifying data collection methods, data
elements, and instruments that are feasible, acceptable, and
support valid inferences. The PRISM elements in Table 2
are conceptualized as affecting these implementation out-
comes. For instance, Reach (i.e., the number, percentage,
and representativeness of patients who receive SDM)
requires accurate identification of all eligible patients, and
determination of whether SDM was delivered to each
patient. For lung cancer screening an important eligibility
criterion, pack years, is not consistently captured in the
electronic health record, limiting an organization’s ability
to evaluate Reach. The challenges inherent in measuring
the SDM process has led some evaluators to focus solely
on outcomes (see Effectiveness in Table 3). A primary focus
has been decision quality, which includes both knowledge
and values/choice concordance. Knowledge is typically
measured using objective questions to document under-
standing of objective information related to the specific
decision. However, there is no accepted standard defining
the minimum level of knowledge or key information that
the patient must understand to be considered ‘‘informed’’
about the decision. The measures used to assess knowledge
related to a given decision vary across studies, precluding
direct comparisons of DAs’ effectiveness.48 Simply provid-
ing information is no guarantee that comprehension has
occurred. Values and preferences, which are subjective,
may be unstable or conflicting, making the determination
of values/choice concordance more complex. Decision
Matlock et al. 9
regret and decisional conflict are also important SDM out-
comes, but patient responses on these measures may be
influenced by factors other than effectiveness, such as trust
in the physician or experiencing surgical complications
from the medical procedure.47,49
A challenge in evaluating SDM Adoption or spread of
SDM is that multiple levels must be considered: clini-
cians are nested within clinics which are in turn nested
within organizations or health care plans, and adoption
at any one level does not ensure adoption at another.
Furthermore, to fully understand adoption decisions,
evaluators must explore reasons for supporting or oppos-
ing adoption at each level. Evaluating Implementation is
also challenging. Ideally, Implementation would be assessed
by observing actual clinician-patient encounters, determin-
ing whether a DA was used, whether the clinician provided
critical information (e.g., the need for annual screening),
and whether the patient’s values and preferences were con-
sidered. While capturing what happens during encounters
is possible, such efforts are resource intensive and often
not feasible in practice. Assessing Implementation through
electronic health record documentation is risky, as time
constraints, reimbursement contingencies, and other fac-
tors may tempt clinicians to document that SDM has
occurred even if most elements are absent, as one recent
study suggests.36 Patients can be queried about their recall
of the decision-making process, but the patient-clinician
relationship, memory, and other factors may influence
their responses.50 Patient surveys are more feasible than
observing or recording encounters, but they still require
resources. Additionally, when measuring implementa-
tion, it is also important to assess fidelity, costs, and
adaptation. It is a well-documented implementation
science fact that interventions are seldom if ever deliv-
ered as conducted in efficacy trials.22 Adaptations will
happen, and it is important to assess them rather than
ignore them.51 Maintenance (or sustainment) refers to
sustained efforts to continue an intervention; thus, eva-
luation of maintenance requires repeated or continuous
assessment of implementation. The methods and
instruments used to assess initial adoption and imple-
mentation are also relevant for assessing maintenance.
In addition, forward-looking interviews with leaders
exploring commitment, intent to continue, and actual
or anticipated adaptations and challenges are needed to
fully understand whether efforts to implement SDM
are truly successful.
Conclusion
This article stresses the importance of thoughtfully imple-
menting and disseminating SDM interventions by con-
sidering conceptual models from implementation science.
The PRISM framework emphasizes contextual factors,
the importance of fit, and implementation science issues
and measures in real-world applications. Having a model
like PRISM can help with planning and evaluation of
SDM programs and policies.18,19 PRISM is not the only
IS framework that could be applied. We chose this frame-
work because of the relative ease for nonresearchers to
understand (compared to many other implementation sci-
ence models) the RE-AIM implementation outcome com-
ponents and because PRISM intentionally focuses on a
smaller, specific set of specific contextual factors that affect
the RE-AIM outcomes. Many other models exist and have
been applied to SDM and DAs including normalization
process theory,52 and the Consolidated Framework for
Implementation Research (CFIR).53 This article presents
one example of the promise of the more general issue of
integrating implementation science and health communica-
tion disciplines into planning, execution, and evaluation of
health care programs and policies.
Considering the importance of context at multiple lev-
els is particularly important for SDM and DAs in that
context varies not just among clinical settings but also
across different decisions in terms of the difficulty in
understanding, the urgency, and the fatefulness of the
decision.24 All of these factors can have different impacts
on different implementation outcomes. Integrating SDM
and implementation science provides guidance on the way
to address the ubiquitous problem of lack of implemen-
tation of evidence-based SDM and on the importance of
‘‘fit’’ among an (SDM) intervention, the implementation
setting, and the implementation strategies to deliver the
intervention. This approach should be helpful for both
researchers and practitioners to conceptualize, reflect on,
and anticipate key contextual issues.
Future research should compare PRISM-guided im-
plementation of SDM to implementation without such
guidance to identify which PRISM elements are most
important for successful implementation and suitability
in which settings and at what phase in the process from
planning, implementation, evaluation, sustainability, and
adaptation. Additionally, DA developers should under-
stand and address the tension between designing DAs
that maximize effectiveness versus DAs that maximize
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pragmatic and population health issues of reach, adop-
tion, implementation, and sustainability.20,25 As CMS
considers additional mandates to support SDM, they
should also consider how best to support and facilitate
implementation. Notably, they should carefully consider
the pros and cons of mandating specific delivery elements
such as having an ‘‘independent noninterventional physi-
cian’’ be mandated to do the SDM as in the case of
LAAC or ‘‘in-person SDM visit’’ as in the case of lung
cancer screening. CMS could stimulate implementation
by being more explicit about which subset of decisions
they are considering these mandates for and what consti-
tutes an ‘‘evidence-based’’ DA. Finally, CMS could assist
DA developers and implementers by explicitly allowing
(and reimbursing for) SDM to occur through telehealth,
which has rapidly become more common as the world
adjusts to the COVID19 pandemic. Indeed, given the
multiple barriers to overcome, perhaps the greatest effect
of these mandates so far has been to spur implementation
in a way that likely would not have occurred otherwise.
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